AR020729A1 - Un metodo para el encapsulado de componentes sensibles en una matriz para obtener particulas discretas y estables durante su almacenamiento - Google Patents

Un metodo para el encapsulado de componentes sensibles en una matriz para obtener particulas discretas y estables durante su almacenamiento

Info

Publication number
AR020729A1
AR020729A1 ARP990105062A ARP990105062A AR020729A1 AR 020729 A1 AR020729 A1 AR 020729A1 AR P990105062 A ARP990105062 A AR P990105062A AR P990105062 A ARP990105062 A AR P990105062A AR 020729 A1 AR020729 A1 AR 020729A1
Authority
AR
Argentina
Prior art keywords
component
matrix
active
plasticizable
liquid
Prior art date
Application number
ARP990105062A
Other languages
English (en)
Spanish (es)
Original Assignee
Gen Mills Marketing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/233,443 external-priority patent/US7201923B1/en
Application filed by Gen Mills Marketing Inc filed Critical Gen Mills Marketing Inc
Publication of AR020729A1 publication Critical patent/AR020729A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/20—Partially or completely coated products
    • A21D13/28—Partially or completely coated products characterised by the coating composition
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/135—Individual or non-extruded flakes, granules or shapes having similar size, e.g. breakfast cereals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
    • A23L9/10—Puddings; Dry powder puddings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/002—Methods
    • B29B7/007—Methods for continuous mixing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/30—Mixing; Kneading continuous, with mechanical mixing or kneading devices
    • B29B7/34—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices
    • B29B7/38—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary
    • B29B7/46—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary with more than one shaft
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B9/00—Making granules
    • B29B9/12—Making granules characterised by structure or composition
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/36—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
    • B29C48/395—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders
    • B29C48/40—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders using two or more parallel screws or at least two parallel non-intermeshing screws, e.g. twin screw extruders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/204—Use of bacteria which are encapsulated, entrapped or immobilised; Fermentation with these bacteria
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B9/00—Making granules
    • B29B9/02—Making granules by dividing preformed material
    • B29B9/06—Making granules by dividing preformed material in the form of filamentary material, e.g. combined with extrusion
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
ARP990105062A 1998-10-09 1999-10-06 Un metodo para el encapsulado de componentes sensibles en una matriz para obtener particulas discretas y estables durante su almacenamiento AR020729A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10370098P 1998-10-09 1998-10-09
US10969698P 1998-11-24 1998-11-24
US09/233,443 US7201923B1 (en) 1998-03-23 1999-01-20 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles

Publications (1)

Publication Number Publication Date
AR020729A1 true AR020729A1 (es) 2002-05-29

Family

ID=27379589

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105062A AR020729A1 (es) 1998-10-09 1999-10-06 Un metodo para el encapsulado de componentes sensibles en una matriz para obtener particulas discretas y estables durante su almacenamiento

Country Status (13)

Country Link
EP (1) EP1119345B1 (enExample)
JP (1) JP5408684B2 (enExample)
AR (1) AR020729A1 (enExample)
AT (1) ATE429813T1 (enExample)
AU (1) AU777977B2 (enExample)
CA (1) CA2345815C (enExample)
CO (1) CO5150196A1 (enExample)
DE (1) DE69940821D1 (enExample)
DK (1) DK1119345T3 (enExample)
ES (1) ES2326502T3 (enExample)
PE (1) PE20001321A1 (enExample)
PT (1) PT1119345E (enExample)
WO (1) WO2000021504A1 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
AU2001287643A1 (en) 2000-07-28 2002-02-13 Henkel Kommanditgesellschaft Auf Aktien Novel amylolytic enzyme extracted from bacillus SP. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6617026B2 (en) 2000-10-02 2003-09-09 Novozymes A/S Particles containing active in visco-elastic liquids
JP2004510876A (ja) * 2000-10-02 2004-04-08 ノボザイムス　アクティーゼルスカブ 粘弾性液体中に活性成分を含有する粒子
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
DE102004039196B4 (de) * 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
US7318920B2 (en) * 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
EP1841428A1 (en) * 2005-01-18 2007-10-10 Immusol Incorporated Novel quinolinium salts and derivatives
AU2006257726B2 (en) * 2005-06-17 2010-09-09 Australian Nuclear Science And Technology Organisation Particles having hydrophobic material therein
JP2008546614A (ja) * 2005-06-17 2008-12-25 オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション 疎水性物質をその中へ含有する粒子
NZ565012A (en) * 2005-06-17 2010-02-26 Australian Nuclear Science Tec Particles comprising a releasable dopant therein
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
SI1993559T1 (sl) 2006-02-03 2017-01-31 Opko Renal, Llc Zdravljenje nezadostnosti in pomanjkanja vitamina D s 25-hidroksivitaminon D2 in 25-hidroksivitaminom D3
DK3357496T3 (da) 2006-06-21 2020-05-11 Opko Ireland Global Holdings Ltd Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
ES3047207T3 (en) 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
PT2148661E (pt) 2007-04-25 2013-03-06 Proventiv Therapeutics Llc Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
CA2684778C (en) 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
CN106853250A (zh) 2008-04-02 2017-06-16 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP3064217B1 (en) 2009-01-06 2018-04-18 Galenagen, LLC Compositions comprising protease, amylase and lipase for use in the treatment of staphylococcus aureus infections
GB2480773B (en) 2009-01-06 2013-12-11 Curelon Llc Compositions for the treatment of diarrhea caused by virulent E. coli infections
DE202009001095U1 (de) 2009-01-26 2010-03-11 Igv Institut Für Getreideverarbeitung Gmbh Verkapselte Wirkstoffe in bioaktiver Matrix
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
CA2762824C (en) * 2009-06-05 2017-10-10 General Mills, Inc. Encapsulated omega-3 fatty acids for baked goods production
JP5810082B2 (ja) * 2009-07-03 2015-11-11 カーギル インコーポレイテッド 粒状フレーバー送達系、その製造方法及びその使用
US20110086085A1 (en) * 2009-10-13 2011-04-14 Wenzel Scott W Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US8926308B2 (en) 2010-04-21 2015-01-06 Intercontinental Great Brands Llc Dough extruders and methods
EP2601221A1 (de) 2010-08-05 2013-06-12 Basf Se Stabilisator
EP3305317B1 (en) 2011-04-21 2020-06-24 Curemark, LLC Compounds for the treatment of neuropsychiatric disorders
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US9560877B2 (en) 2012-03-13 2017-02-07 General Mills, Inc. Cereal-based product with improved eating quality fortified with dietary fiber and/or calcium
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CA2913971C (en) * 2013-05-31 2022-08-02 Universal Stabilization Technologies, Inc. Polymeric compositions containing ambient-temperature stable biopharmaceuticals & methods for formulation thereof
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
HUE053666T2 (hu) * 2015-12-23 2021-07-28 Sonneveld Group B V Keményítõ részecskéket tartalmazó tésztakeverék nyílt bélszerkezetû péksütemények elõállítására
JP5945087B1 (ja) * 2016-03-16 2016-07-05 株式会社大貴 排泄物処理材の製造方法及び製造装置
WO2017182237A1 (en) 2016-03-28 2017-10-26 Opko Ireland Global Holdings, Limited Methods of vitamin d treatment
MX395099B (es) * 2016-04-14 2025-03-24 Mars Inc Compuestos que modulan actividad del receptor de deteccion de calcio para modular el sabor kokumi y productos de alimentos para mascotas que contiene los mismos.
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
US20210000157A1 (en) * 2018-03-15 2021-01-07 Dsm Ip Assets B.V. Extrudate comprising vitamin a
WO2019175331A1 (en) * 2018-03-15 2019-09-19 Dsm Ip Assets B.V. Extrusion of oxidable actives
CN109432817A (zh) * 2018-11-02 2019-03-08 江阴天江药业有限公司 一种含热敏性有效成分的中药的自动化提取分离方法及配方颗粒制备方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN113350315B (zh) * 2021-06-10 2022-09-06 黑龙江澳利达奈德制药有限公司 一种别嘌醇缓释胶囊及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191015312A (en) * 1910-06-25 1911-03-23 John Hutcheon Improved Process of Producing Cooked Foods Impregnated with certain Bacteria.
US3786123A (en) * 1971-01-25 1974-01-15 S Katzen Method for stabilizing and preserving nutrients and products
EP0202409A3 (en) 1985-03-25 1989-02-01 Miles Inc. A process for the production of viable and stable dry microorganisms for food and agricultural purposes
US5314692A (en) 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
JP2695247B2 (ja) * 1988-06-13 1997-12-24 ビーエーエスエフ・ケー・アンド・エフ・コーポレイシヨン コレスチルアミンを含有する食用の焼いた組成物
US5079012A (en) * 1989-06-07 1992-01-07 Nabisco Brands, Inc. Shelf stable cookie product containing heat and shear sensitive additives and method of making
WO1990015537A1 (en) * 1989-06-07 1990-12-27 Nabisco Brands, Inc. Extrusion baking of cookies having liposome encapsulated ingredients
JPH0463563A (ja) * 1990-07-03 1992-02-28 Terumo Corp 抗肥満性食品およびその製造方法
US5074902A (en) * 1990-07-30 1991-12-24 Connick Jr William J Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds
DE4041752A1 (de) * 1990-12-24 1992-06-25 Henkel Kgaa Enzymzubereitung fuer wasch- und reinigungsmittel
US5508053A (en) 1993-08-13 1996-04-16 Kraft Foods, Inc. Method for producing vegetable pasta
ES2565163T3 (es) * 1996-10-28 2016-03-31 General Mills, Inc. Imbibición y encapsulación de partículas de liberación controlada y producto encapsulado
IL133280A0 (en) 1997-06-04 2001-04-30 Dsm Nv High-activity phytase granulate
AU747549B2 (en) 1998-03-23 2002-05-16 General Mills Inc. Encapsulation of components into edible products

Also Published As

Publication number Publication date
DK1119345T3 (da) 2009-08-03
WO2000021504A1 (en) 2000-04-20
DE69940821D1 (de) 2009-06-10
JP2002527375A (ja) 2002-08-27
CA2345815C (en) 2011-02-08
AU6387299A (en) 2000-05-01
WO2000021504A8 (en) 2000-06-22
EP1119345A1 (en) 2001-08-01
PE20001321A1 (es) 2000-12-01
JP5408684B2 (ja) 2014-02-05
CA2345815A1 (en) 2000-04-20
CO5150196A1 (es) 2002-04-29
EP1119345A4 (en) 2004-06-16
ATE429813T1 (de) 2009-05-15
AU777977B2 (en) 2004-11-04
PT1119345E (pt) 2009-07-27
EP1119345B1 (en) 2009-04-29
ES2326502T3 (es) 2009-10-13

Similar Documents

Publication Publication Date Title
AR020729A1 (es) Un metodo para el encapsulado de componentes sensibles en una matriz para obtener particulas discretas y estables durante su almacenamiento
CO5200846A1 (es) Encapsulado de componentes sensibles en una matriz para obtener particulas discretas estables durante el almacenamiento
CN1098105C (zh) 用于治疗牙周炎的可生物降解的持续释放制剂
US3982537A (en) Dynamic implants and method for implanting the same
AR026190A1 (es) Material activo encapsulado inmovilizado en microesferas de hidrogel
ES2151541T3 (es) Microesferas que contienen hormona del crecimiento de liberacion prolongada.
NO992036L (no) Innst°ping og innkapsling av partikler med styrt frigivelse
IE873213L (en) Galenical Formulation
AR013151A1 (es) COMPOSICIoN Y MÉTODO DE LIBERACIoN CONTROLADA PARA SUMUNISTRAR UN PRODUCTO QUíMICO AGRíCOLA A UNA PLANTA Y MÉTODO PARA PRODUCIR UNA COMPOSICIoN.
NO178605B (no) Apparat for tilförsel av preparat med vedvarende avgivelse av et farmasöytisk middel til crevikularlommen for behandling av tannrotsykdom
ATE112139T1 (de) Verkapselung von mischgetrockneter sucralose mit polyvinylacetat zur verwendung in kaugummi.
NO872499L (no) FremgangsmŸte for behandling av et biologisk aktivt stoff.
ES2180706T3 (es) Metodo para producir una preparacion de liberacion prolongada.
CN113499444A (zh) 氧气缓释材料及其制备方法和药物
RU96124095A (ru) Применение геля в качестве протравителя
ES2010943A6 (es) Composiciones encapsuladas conteniendo un antiespumante siliconico.
ES2103969T3 (es) Composicion de reactivo en dosis unitaria para dosificados por union especifica.
ES2080703B1 (es) Metodos de estabilizacion de sustancias medicamentosas incorporadas a pastillas de chicle.
CA1079636A (en) Dynamic implants and method for implanting the same
CN101366376A (zh) 一种杀血吸虫尾蚴的氯硝柳胺控释扩散剂及其制备方法
KR970700505A (ko) 산 활성물질을 갖는 경구투여 형태 및 그의 제조방법(oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same)
CN111096320A (zh) 养殖池专用选择性氧化二氧化氯缓释片剂
CN112057477A (zh) 一种蜂胶中药丸剂的制作方法
CA2249713A1 (en) Injection method for administering microparticles containing active substances to plants
JP2847095B2 (ja) 汚水・汚泥処理方法

Legal Events

Date Code Title Description
FB Suspension of granting procedure